Response to steroid treatment in anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff person syndrome and polyendocrinopathy [1]

Movement Disorders

Volumn 21, Issue 12, 2006, Pages 2263-2264

  Kim, Ji Youn ^a   Chung, Eun Joo ^a   Kim, Jong Hun ^a   Jung, Ki Young ^a   Lee, Won Yong ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY; METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

ADULT; ANTIBODY DETECTION; ATAXIA; BACKACHE; CASE REPORT; CEREBELLAR ATAXIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG RESPONSE; DYSMETRIA; FEMALE; GAIT DISORDER; HASHIMOTO DISEASE; HUMAN; JOINT LIMITATION; LETTER; NEUROLOGIC EXAMINATION; POLYENDOCRINOPATHY; PRIORITY JOURNAL; STEROID THERAPY; STIFF MAN SYNDROME;

ADULT; ANTIBODIES; CEREBELLAR ATAXIA; FEMALE; FOLLOW-UP STUDIES; GLUTAMATE DECARBOXYLASE; HUMANS; ISOENZYMES; POLYENDOCRINOPATHIES, AUTOIMMUNE; STEROIDS; STIFF-PERSON SYNDROME;

EID: 33846428771     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21041     Document Type: Letter

References (9)

1. Dalakas MC, Li M, Fujii M, Jacobowitz DM. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Neurology 2001;57:780-784.
2. Tuomi T, Bjorses P, Falorni A, et al. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 1996;81:1488-1494.
3. Honnorat J, Saiz A, Giometto B, et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 2001;58:225-230.
4. Nemni R, Braghi S, Natali-Sora MG, et al. Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol 1994;36:665-667.
5. Trouillas P, Takayanagi T, Hallett M, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 1997;145:205-211.
6. Dalakas MC. The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies. J Neurol 2005;252(Suppl. 1):119-125.
7. Rakocevic G, Raju R, Dalakas MC. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity. Arch Neurol 2004;61:902-904.
8. Lauria G, Pareyson D, Pitzolu MG, Bazzigaluppi E. Excellent response to steroid treatment in anti-GAD cerebellar ataxia. Lancet Neurol 2003;2:634-635.
9. Ances BM, Dalmau JO, Tsai J, Hasbani MJ, Galetta SL. Downbeating nystagmus and muscle spasms in a patient with glutamic-acid decarboxylase antibodies. Am J Ophthalmol 2005;140:142-144.